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Gornik and colleagues should be commended for 
providing the ﬁ   rst report on the long-term glucose 
metabolism sequelae in survivors of critical illness with 
no apparent dysglycemia shortly after hospital discharge 
[1]. Th   e authors hypothesized that hyperglycemia in the 
intensive care unit unmasks predisposition for future 
development of diabetes. Th  e interpretation of their 
ﬁ  ndings, however, is limited by several aspects of their 
methodology.
No systematic control for covariates and confounders 
was performed. Th  eir cohort was divided, as acknow-
ledged by the authors, by an arbitrary (for the purpose of 
long-term prediction) glycemic cutoﬀ    value. While 
intuitively appealing, the latter is not necessarily the 
optimal predictor of future risk of impaired glucose 
metabolism. When considering the whole cohort of 
patients with a normal ﬁ   rst postdischarge oral glucose 
toler  ance test (the eligible cohort), what was the predic  tive 
role for traditional predictors of diabetes mellitus and 
prediabetes mellitus (DM/pre-DM) (for example, age, 
family history, body mass index) and for inhospital 
variables (for example, severity of illness)? It would also 
be instructive to explore the role of previously studied 
glycemic indices – such as admission, maximal and mean 
glucose values – to determine the best predictive cutoﬀ   
value for future development of DM/pre-DM.
In addition, almost 40% of the eligible cohort was 
excluded from analysis due to death or discontinuation of 
follow-up. How many of these patients who had at least 
the ﬁ  rst 12-month follow-up were diagnosed with DM/
pre-DM?
Because DM/pre-DM are commonly under-recognized 
[2], these analyses can provide initial predictive 
modeling, which may inform future development of 
public health policy for earlier detection and intervention 
in survivors of critical illness.
© 2010 BioMed Central Ltd
The long-term metabolic outcomes of dysglycemia 
during critical illness
Lavi Oud*
See related research by Gornik et al., http://ccforum.com/content/14/4/R130
LETTER
*Correspondence: lavi.oud@ttuhsc.edu
Division of Pulmonary and Critical Care Medicine, Department of Internal 
Medicine, Texas Tech University Health Sciences Center at the Permian Basin, 
701 West 5th Street, Odessa, TX 79763, USA
Authors’ response
Ivan Gornik
We appreciate Dr Oud’s sound comments to the limita-
tions of our study [1]; we will try to address them all.
Analysis of covariates was performed, although the 
results were not included in the paper. Family history of 
diabetes and body mass index were, in univariate analyses, 
associated with higher 5-year incidence of diabetes; higher 
Acute Physiology and Chronic Health Evaluation II score 
was associated with lower 5-year incidence of diabetes. A 
logistic regression model that included age, family history 
of diabetes, body mass index, Acute Physiology and 
Chronic Health Evaluation II score and intensive care unit 
hyperglycemia revealed only the ﬁ   nal variable as an 
independent predictor of future diabetes (Table 1).
Severity of illness was associated with lower risk of 
diabetes. We have also previously reported the incidence 
of diabetes following hyperglycemia in sepsis according 
to the severity of disease [3]. Relative risks for DM in 
patients who had hyperglycemia in mild sepsis and septic 
shock were 6.94 and 2.20, respectively. Th   e hypothesis is 
that more severe illness can produce hyperglycemia more 
frequently even in patients without a predisposition to 
diabetes, therefore reducing the discriminating capability.
Besides the chosen threshold of 7.7 mmol/l, other 
possible thresholds and glycemic variables (admission, 
highest and mean glucose) were possible predictors of 
future diabetes, but none showed better results in our 
popu  lation. Future studies may show their value, 
especially in popu  lations other than medical intensive 
care unit patients.
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© 2010 BioMed Central LtdTh   e dropout rate was indeed high and the numbers of 
patients decreased after the ﬁ  rst years of follow-up. Th  e 
diﬀ  erence in the incidence of diabetes became signiﬁ  cant 
only after 2 years: 3.1% of patients (9/290) in the hyper-
glycemia group and 0.7% of patients (4/539) in the 
normo  glycemia group were diagnosed with diabetes 
(P  =  0.023). Th  e 2-year period could therefore be the 
minimal follow-up target in future studies.
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Table 1. Logistic regression model for 5-year risk of diabetes mellitus in patients admitted to the ICU
Independent variable  Odds ratio (95% CI)  P value
Hyperglycemia (>7.7 mmol/l) in the ICU  5.04 (2.48 to 10.26)  <0.001
Body mass index (kg/m2) – for each increment of 1 kg/m2  1.44 (0.93 to 2.22)  0.10
Age (years) – for each increment of 1 year  0.89 (0.77 to 1.03)  0.13
Family history of diabetes  0.87 (0.22 to 2.03)  0.48
APACHE II score – for each increment of 1 point  0.63 (0.13 to 1.19)  0.09
APACHE, Acute Physiology and Chronic Health Evaluation; CI, confi  dence interval; ICU, intensive care unit.
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